KANDY THERAPEUTICS LIMITED
Research and experimental development on biotechnology
KANDY THERAPEUTICS LIMITED
Research and experimental development on biotechnology
Contact & Details
Contact
Registered Address
400 South Oak Way Reading RG2 6AD England
Full company profile for KANDY THERAPEUTICS LIMITED (10753028), an active life sciences and medical technology company based in Reading, England. Incorporated 3 May 2017. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.
Business Summary
This company specializes in providing innovative solutions and services across multiple sectors. Sign up to viewReports
Credit Report
In-depth credit score, financial analysis, risk assessment and company intelligence.
Financials
Financials
Balance Sheet & P&L (2018–2024)
Cash in Bank
N/A
Net Assets
£79.35M
Total Liabilities
£22.59M
Turnover
£100.20M
Employees
2
Debt Ratio
22%
Financial History
Revenue, profit, EBITDA and key financial figures
2024 Dec Year End | 2023 Dec Year End | |
|---|---|---|
| P&L | ||
| Revenue | ||
| Gross Profit | ||
| Operating Profit | ||
| Net Profit | ||
| EBITDA | ||
| Assets | ||
| Cash | ||
| Total Assets | ||
| Liabilities | ||
| Total Liabilities | ||
| Key Metrics | ||
| Employees | ||
Funding
Fundraising & Grants
Investors (6)
| Investor Name | Investor Since | Participating Rounds |
|---|---|---|
| Investor 2 | Aug 2018 | Series C |
| Investor 3 | Aug 2018 | Series C |
| Investor 4 | Aug 2018 | Series C |
See all 6 investors
Sign up to view complete investor information
Officers
Officers
| Status | |||||||
|---|---|---|---|---|---|---|---|
No officers found | |||||||
No officers found
See all 15 officers
Sign up to view the full officer history
Persons with Significant Control
Persons with Significant Control (1)
Bayer Global Investments Bv
Netherlands
- Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors
Michael Keith Trower
Ceased 14 Sept 2017
Advent Life Sciences Llp
Ceased 24 Aug 2018
Group Structure
Group Structure
Charges
Charges
No charges registered
Properties
Properties
No related properties
Documents
Company Filings
| Date | Category | Description | Document |
|---|---|---|---|
| 7 Mar 2026 | Capital | Capital Name Of Class Of Shares | |
| 4 Jun 2025 | Confirmation Statement | Confirmation statement made on 24 May 2025 with updates | |
| 23 May 2025 | Capital | Capital Name Of Class Of Shares | |
| 9 May 2025 | Accounts | Annual accounts made up to 31 Dec 2024 | |
| 14 Mar 2025 | Officers | Termination of Ramon Antonio Payano Baez as director on 14 Mar 2025 |
Capital Name Of Class Of Shares
Confirmation statement made on 24 May 2025 with updates
Capital Name Of Class Of Shares
Annual accounts made up to 31 Dec 2024
Termination of Ramon Antonio Payano Baez as director on 14 Mar 2025
Recent Activity
Latest Activity
Capital Name Of Class Of Shares
1 months ago on 7 Mar 2026
Confirmation statement made on 24 May 2025 with updates
11 months ago on 4 Jun 2025
Capital Name Of Class Of Shares
11 months ago on 23 May 2025
Annual accounts made up to 31 Dec 2024
11 months ago on 9 May 2025
Termination of Ramon Antonio Payano Baez as director on 14 Mar 2025
1 years ago on 14 Mar 2025